ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 125 filers reported holding ACORDA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,012,000 | -95.5% | 7,791 | -93.6% | 0.00% | – |
| Q2 2020 | $89,898,000 | +400.2% | 122,377 | +535.0% | 0.00% | – |
| Q1 2020 | $17,973,000 | -56.9% | 19,272 | -5.8% | 0.00% | – |
| Q4 2019 | $41,738,000 | +77.8% | 20,460 | +150.2% | 0.00% | – |
| Q3 2019 | $23,471,000 | -48.9% | 8,178 | +36.5% | 0.00% | – |
| Q2 2019 | $45,966,000 | -66.2% | 5,993 | -41.5% | 0.00% | – |
| Q1 2019 | $136,103,000 | +727.3% | 10,241 | +869.8% | 0.00% | – |
| Q4 2018 | $16,452,000 | -94.8% | 1,056 | -93.4% | 0.00% | – |
| Q3 2018 | $315,854,000 | +362.0% | 16,074 | +574.8% | 0.00% | – |
| Q2 2018 | $68,363,000 | -80.0% | 2,382 | -83.5% | 0.00% | -100.0% |
| Q1 2018 | $341,009,000 | -14.2% | 14,419 | -22.2% | 0.00% | 0.0% |
| Q4 2017 | $397,619,000 | -29.7% | 18,537 | -22.5% | 0.00% | 0.0% |
| Q3 2017 | $565,330,000 | +104.1% | 23,904 | +70.1% | 0.00% | 0.0% |
| Q2 2017 | $276,923,000 | +40.7% | 14,057 | +50.0% | 0.00% | 0.0% |
| Q1 2017 | $196,791,000 | +4.8% | 9,371 | -6.2% | 0.00% | 0.0% |
| Q4 2016 | $187,793,000 | +32.0% | 9,989 | +46.6% | 0.00% | 0.0% |
| Q3 2016 | $142,318,000 | -60.9% | 6,816 | -52.2% | 0.00% | -50.0% |
| Q2 2016 | $363,834,000 | +109.9% | 14,268 | +117.7% | 0.00% | +100.0% |
| Q1 2016 | $173,353,000 | -53.9% | 6,554 | -25.5% | 0.00% | 0.0% |
| Q4 2015 | $376,208,000 | +59.1% | 8,794 | -1.4% | 0.00% | 0.0% |
| Q3 2015 | $236,469,000 | +99.3% | 8,920 | +150.6% | 0.00% | – |
| Q2 2015 | $118,655,000 | +260.5% | 3,560 | +260.0% | 0.00% | – |
| Q1 2015 | $32,914,000 | -61.4% | 989 | -60.7% | 0.00% | – |
| Q3 2014 | $85,174,000 | +1369.0% | 2,514 | +1361.6% | 0.00% | – |
| Q2 2014 | $5,798,000 | +79.7% | 172 | +89.0% | 0.00% | – |
| Q1 2014 | $3,226,000 | -79.0% | 91 | -82.7% | 0.00% | – |
| Q4 2013 | $15,359,000 | -96.0% | 526 | -95.3% | 0.00% | – |
| Q3 2013 | $383,211,000 | -18.1% | 11,205 | -21.0% | 0.00% | – |
| Q2 2013 | $468,029,000 | – | 14,187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |